Taysha Gene Therapies announces Nasdaq inducement grant under Rule 5635(c)(4)
Taysha Gene Therapies, Inc. announced an inducement grant under Nasdaq Listing Rule 5635(c)(4).
DALLAS, Sept.
04, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc.
NASDAQ:TSHA (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announce…